Landscape Capital Management L.L.C. boosted its position in shares of Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 155.1% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 106,034 shares of the company's stock after buying an additional 64,469 shares during the period. Landscape Capital Management L.L.C.'s holdings in Keurig Dr Pepper were worth $3,628,000 at the end of the most recent quarter.
Other large investors have also recently bought and sold shares of the company. ST Germain D J Co. Inc. acquired a new stake in Keurig Dr Pepper during the first quarter worth about $27,000. Continuum Advisory LLC grew its stake in Keurig Dr Pepper by 82.5% during the first quarter. Continuum Advisory LLC now owns 1,332 shares of the company's stock worth $46,000 after buying an additional 602 shares in the last quarter. Global Trust Asset Management LLC acquired a new stake in Keurig Dr Pepper during the first quarter worth about $48,000. LRI Investments LLC grew its stake in Keurig Dr Pepper by 65.6% during the fourth quarter. LRI Investments LLC now owns 1,527 shares of the company's stock worth $49,000 after buying an additional 605 shares in the last quarter. Finally, Riverview Trust Co grew its stake in Keurig Dr Pepper by 47.7% during the first quarter. Riverview Trust Co now owns 1,710 shares of the company's stock worth $59,000 after buying an additional 552 shares in the last quarter. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Keurig Dr Pepper Price Performance
Shares of KDP traded down $0.20 during mid-day trading on Friday, reaching $29.09. The company had a trading volume of 22,200,454 shares, compared to its average volume of 14,551,858. The company's 50 day simple moving average is $33.36 and its 200 day simple moving average is $33.60. The company has a market capitalization of $39.52 billion, a price-to-earnings ratio of 25.97, a P/E/G ratio of 1.59 and a beta of 0.45. Keurig Dr Pepper, Inc has a 1-year low of $28.70 and a 1-year high of $38.28. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.49. The business had revenue of $4.16 billion during the quarter, compared to analyst estimates of $4.14 billion. Keurig Dr Pepper had a net margin of 9.75% and a return on equity of 11.05%. The firm's quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the business earned $0.45 EPS. Analysts expect that Keurig Dr Pepper, Inc will post 1.92 EPS for the current year.
Insider Activity at Keurig Dr Pepper
In related news, insider Mary Beth Denooyer sold 12,000 shares of the firm's stock in a transaction that occurred on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the transaction, the insider owned 82,511 shares in the company, valued at $2,777,320.26. This trade represents a 12.70% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert James Gamgort sold 208,000 shares of the firm's stock in a transaction that occurred on Friday, August 1st. The shares were sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the completion of the transaction, the director owned 2,292,169 shares of the company's stock, valued at approximately $75,412,360.10. This trade represents a 8.32% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 679,601 shares of company stock worth $22,508,712 in the last quarter. 0.40% of the stock is owned by insiders.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. Barclays increased their price objective on shares of Keurig Dr Pepper from $37.00 to $39.00 and gave the stock an "overweight" rating in a research note on Monday, July 28th. Hsbc Global Res downgraded shares of Keurig Dr Pepper from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 26th. JPMorgan Chase & Co. reduced their price target on shares of Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating on the stock in a research note on Thursday, July 17th. HSBC restated a "hold" rating and issued a $30.00 price target (down from $42.00) on shares of Keurig Dr Pepper in a research note on Tuesday, August 26th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating on the stock in a research note on Tuesday, August 26th. Eleven investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $38.38.
View Our Latest Stock Analysis on KDP
About Keurig Dr Pepper
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.